首页> 外文OA文献 >Maribavir Versus Valganciclovir for Pre-Emptive Treatment of Cytomegalovirus Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant and Solid Organ Transplant Recipients

【2h】

Maribavir Versus Valganciclovir for Pre-Emptive Treatment of Cytomegalovirus Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant and Solid Organ Transplant Recipients

机译：Maribavir与Valganciclovir用于鼻腔病毒病毒血症的先发制人毒性：造血干细胞移植和固体器官移植受体的随机剂量，阶段2研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Johan A. Maertens; Catherine Cordonnier; Peter Jaksch; Xavier Poiré; Jingyang J. Wu; Anna Wijatyk; Faouzi Saliba; Oliver Witzke; Stephen Villano;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 化疗联合单一剂量rhG-CSF用于自体外周血造血干细胞移植的临床研究 [J] . 田红, 周淑芸癌症（英文版） . 2002,第008期
2. Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study [J] . Papanicolaou Genovefa A., Silveira Fernanda P., Langston Amelia A., Clinical infectious diseases . 2019,第8期

机译：Maribavir用于造血 - 细胞或固体器官移植受者的难治性或抗性细胞瘤病毒感染：随机，剂量范围，双盲，第2期研究
3. Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial [J] . Asberg Anders, Humar Atul, Rollag Halvor, Clinical infectious diseases . 2016,第9期

机译：从口服缬更昔洛韦与肠胃外更昔洛韦治疗实体器官移植受者巨细胞病毒病的随机研究中获得的经验教训：VICTOR试验
4. Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. [J] . Winston DJ, Young JA, Pullarkat V, Blood: The Journal of the American Society of Hematology . 2008,第11期

机译：马里巴韦预防预防同种异体干细胞移植受者巨细胞病毒感染的研究：一项多中心，随机，双盲，安慰剂对照，剂量范围研究。
5. HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS (AL): AN ABMTR STUDY [C] . DH Vesole, W Perez, D Reece, International Symposium on Amyloidosis . 2005

机译：具有自体造血干细胞移植（HSCT）的高剂量治疗用于初级全身淀粉样蛋白症（AL）的患者：ABMTR研究
6. Beta Lactam and Other Antibiotic Allergies in Solid Organ and Hematopoietic Cell Transplant Recipients [D] . Imlay, Hannah M. 2019

机译：固体器官和造血细胞移植受者的β内酰胺和其他抗生素过敏症
7. Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized Dose-ranging Double-blind Phase 2 Study [O] . Genovefa A Papanicolaou, Fernanda P Silveira, Amelia A Langston, -1

机译：马立巴韦用于造血细胞或固体器官移植受者中难治性或耐药性巨细胞病毒感染的随机剂量范围双盲2期研究
8. Maribavir for Treatment of Cytomegalovirus (CMV) Infections Resistant or Refractory to Ganciclovir or Foscarnet in Hematopoietic Stem Cell Transplant (SCT) or Solid Organ Transplant (SOT) Recipients: A Randomized, Dose-Ranging, Double-Blind, Phase 2 Study [O] . Genovefa Papanicolaou, Fernanda P. Silveira, Amelia Langston, 2016

机译：Maribavir用于治疗巨细胞病毒（CMV）感染抗性或难治于造血干细胞移植（SCT）或固体器官移植（SOT）接受者的抗性或Foscarnet：随机，剂量范围，双盲，第2期研究

Maribavir Versus Valganciclovir for Pre-Emptive Treatment of Cytomegalovirus Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant and Solid Organ Transplant Recipients

著录项

引文网络

相似文献

相关主题

期刊订阅